Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
very engaged, close to the employees
Qual é a melhor parte das suas compensações?
annual bonus is fairly distributed
Quais são algumas das melhores coisas da sua equipe?
team members are knowledgeable and we help each other
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
the thinking and all the activities are for the patients
O que faz você mais feliz no trabalho?
I have got the opportunity to be involved in the development of the drug until market approval
Other Employee Reviews for Karyopharm Therapeutics
×